DALLAS: Staff and patients at Wirral mental health trust are taking part in a pioneering research program that could lead to a new way combat Alzheimer’s.
Cheshire and Wirral Partnership trust’s research team led by consultant Psychiatrist Jose Ferran are working with a Swiss pharmaceutical and research company to trial a new vaccine.
The jab inhibits growth of “tangles” in the brain – a typical characteristic of the disease – and aims to slow the decline in Alzheimer’s disease.
The group is working closely with colleagues in the clinical research unit at Royal Liverpool Hospital to provide trial therapy to six Wirral-based patients.
This is a significant number of the program’s overall patient cohort, which includes just ten in the UK and 24 globally…